Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001096906-23-002006
Filing Date
2023-10-17
Accepted
2023-10-17 17:00:12
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q/A SEC FILING tpia-20220331.htm   iXBRL 10-Q/A 407344
  Complete submission text file 0001096906-23-002006.txt   2532440

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20220331_cal.xml EX-101.CAL 17664
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20220331_def.xml EX-101.DEF 59534
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20220331_lab.xml EX-101.LAB 145925
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20220331_pre.xml EX-101.PRE 130400
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20220331.xsd EX-101.SCH 30258
45 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20220331_htm.xml XML 329662
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-56022 | Film No.: 231330231
SIC: 2833 Medicinal Chemicals & Botanical Products